AP1867
|
AP1867
|
195514-23-9
|
SLF TFA
|
|
2378802-47-0
|
FKBP12 PROTAC dTAG-7
|
FKBP12 PROTAC DTAG-7
|
2064175-32-0
|
AP1867-3-(aminoethoxy)
|
AP1867-3-(Methoxyethylamine)
|
2127390-15-0
|
KB02-SLF
|
KB02-SLF
|
2384184-40-9
|
Quiflapon sodium
|
喹夫拉朋钠
|
147030-01-1
|
AM103
|
AM 103
|
1147872-22-7
|
Diflapolin
|
双黄素
|
724453-98-9
|
TAK-659 hydrochloride
|
TAK-659 (HYDROCHLORIDE)
|
1952251-28-3
|
MRX-2843
|
UNC-2371A
|
1429882-07-4
|
TG101209
|
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺
|
936091-14-4
|
FLT3-IN-3
|
SAN50900
|
2229050-90-0
|
UNC2025 hydrochloride
|
UNC2025 盐酸盐
|
2070015-17-5
|
Gilteritinib
|
吉列替尼
|
1254053-43-4
|
Gilteritinib hemifumarate
|
GILTERITINIB FUMARATE
|
1254053-84-3
|
FLT3-IN-6
|
FLT3-IN-6
|
2377141-31-4
|
Fostamatinib Disodium
|
R788(FOSTAMATINIB DISODIUM)
|
1025687-58-4
|
OTS447
|
化合物 OTS447
|
1356943-67-3
|
HM43239
|
化合物HM43239
|
2294874-49-8
|
ATH686
|
化合物ATH 686
|
853299-52-2
|
4SC-203
|
4SC-203
|
895533-09-2
|
Fostamatinib
|
福他替尼
|
901119-35-5
|
Emavusertib
|
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-
|
1801344-14-8
|
Pacritinib
|
帕克替尼
|
937272-79-2
|
AG-09/1
|
2-[(6-methoxy-1H-benzimidazol-2-yl)thio]-N-(4-nitrophenyl)-acetamide
|
356776-32-4
|
HCH6-1
|
D-Phenylalanine, N-benzoyl-L-tryptophyl-, methyl ester
|
1435265-06-7
|
FPR Agonist 43
|
1-(4-氯苯基)-3-(5-异丙基-1-甲基-3-氧亚基-2-苯基-2,3-二氢-1H-吡唑-4-基)脲
|
903895-98-7
|
{Boc}-Phe-Leu-Phe-Leu-Phe
|
BOC-PHE-D-LEU-PHE-D-LEU-PHE-OH
|
66556-73-8
|
BMS-986235
|
BMS-986235
|
2253947-47-4
|
GPR120 Agonist 2
|
3-(4-((5-氯-2,2-二甲基-2,3-二氢苯并呋喃-7-基)甲氧基)-2,3-二甲基苯基)丙酸
|
1234844-11-1
|
GPR40/FFAR1 modulator 1
|
GPR40/FFAR1 modulator 1
|
874755-26-7
|
TUG-1375
|
(2R,4R)-2-(2-氯苯基)-3-(4-(3,5-二甲基异恶唑-4-基)苯甲酰)噻唑烷-4-甲酸
|
2247372-59-2
|
AMG7703
|
(S)-2-(4-chlorophenyl)-3-Methyl-N-(thiazol-2-yl)butanaMide
|
1103523-24-5
|
TUG-469
|
TUG-469
|
1236109-67-3
|
AM-4668
|
AM-4668
|
1011531-27-3
|
GPR40 Activator 2
|
化合物 T11457
|
1312787-30-6
|
AM-1638
|
化合物 T14200
|
1142214-62-7
|
GPR40 agonist 6
|
化合物 GPR40 AGONIST 6
|
1798751-25-3
|
LY2922470
|
LY2922470
|
1423018-12-5
|
AH 7614
|
AH 7614
|
6326-06-3
|
Fezagepras sodium
|
1254472-97-3
|
1254472-97-3
|
TUG-770
|
TUG-770
|
1402601-82-4
|
TAK-875
|
TAK-875
|
1000413-72-8
|
FB23
|
FB23
|
2243736-35-6
|
PX20606 trans racemate
|
CPDD1220反式消旋体
|
1268244-85-4
|
LY2562175
|
化合物LY2562175
|
1103500-20-4
|
Cilofexor
|
CILOFEXOR; GS-9674; GS 9674; GS9674;
|
1418274-28-8
|
DY268
|
DY 268
|
1609564-75-1
|
Vidofludimus
|
维多氟拉迪莫
|
717824-30-1
|
Vonafexor
|
YP001
|
1192171-69-9
|
Tropifexor
|
Tropifexor
|
1383816-29-2
|
ODM-203
|
ODM203
|
1430723-35-5
|
BLU9931
|
BLU 9931
|
1538604-68-0
|
CPL304110
|
化合物 CPL304110
|
1627826-19-0
|
Gunagratinib
|
GUNAGRATINIB
|
2211082-53-8
|
CP-547632
|
3-[(4-溴-2,6-二氟苄基)氧基]-5-[3-[4-(吡咯烷-1-基)丁基]脲基]异噻唑-4-甲酰胺
|
252003-65-9
|
CP-547632 hydrochloride
|
CP-547632 (hydrochloride)
|
252003-71-7
|
R1530
|
5-(2-氯苯基)-7-氟-1,2-二氢-8-甲氧基-3-甲基吡唑并[3,4-B][1,4]苯并二氮杂卓
|
882531-87-5
|
FGFR-IN-1
|
|
1513860-41-7
|
SSR128129E
|
SSR128129E
|
848318-25-2
|
FIIN-2
|
FIIN-2
|
1633044-56-0
|
PP58
|
Pyrido[2,3-d]pyrimidin-7(8H)-one,2-[[4-(2-aminoethoxy)phenyl]amino]-6-(2,6-dichlorophenyl)-8-methyl-
|
212391-58-7
|
Zoligratinib
|
DEBIO-1347
|
1265229-25-1
|
Derazantinib
|
德拉赞替尼
|
1234356-69-4
|
Derazantinib Racemate
|
化合物 T10997
|
2309668-44-6
|
ASP5878
|
ASP-5878
|
1453208-66-6
|
Bemarituzumab
|
贝马里妥珠单抗
|
1952272-74-0
|
BO-264
|
BO-264
|
2408648-20-2
|
Ponatinib hydrochloride
|
泊那替尼盐酸盐
|
1114544-31-8
|
KW-2449
|
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
|
1000669-72-6
|
S49076
|
CS-2684
|
1265965-22-7
|
TG 100572 Hydrochloride
|
4-氯-3-[5-甲基-3-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-1,2,4-苯并三嗪-7-基]苯酚单盐酸盐
|
867331-64-4
|
FGFR1/DDR2 inhibitor 1
|
FGFR1/DDR2 inhibitor 1
|
2308497-58-5
|
FIIN-3
|
FIIN-3
|
1637735-84-2
|
MAX-40279 hemifumarate
|
化合物 MAX-40279 HEMIFUMARATE
|
2388506-43-0
|
MAX-40279 hemiadipate
|
化合物 MAX-40279 HEMIADIPATE
|
2388506-44-1
|
Surfen dihydrochloride
|
1,3-bis(4-amino-2-methyl-6-quinolyl)urea dihydrochloride
|
5424-37-3
|
SU4984
|
CIVENTICHEM CV-409
|
186610-89-9
|
ASN03576800
|
ASN03576800
|
957513-35-8
|
DSHS00884
|
DSHS00884
|
675104-49-1
|
EBOV/MARV-IN-1
|
VUN65671
|
2479465-67-1
|
2'-Deoxy-5'-O-DMT-2'-fluorouridine
|
5'-O-[双(4-甲氧基苯基)(苯基)甲基]-2'-脱氧-2'-氟尿苷
|
146954-74-7
|
SAFit1
|
SAFit1
|
1643125-32-9
|
SLF-amido-C2-COOH
|
SLF-amido-C2-COOH
|
1092369-24-8
|
Shield-1
|
化合物SHIELD-1
|
914805-33-7
|
AP1867-2-(carboxymethoxy)
|
FKBP12 LIGAND
|
2230613-03-1
|
FKBP12 PROTAC dTAG-13
|
FKBP12 PROTAC DTAG-13
|
2064175-41-1
|
PROTAC FLT-3 degrader 1
|
PROTAC FLT-3 DEGRADER 1
|
2230826-81-8
|
JK-P3
|
3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺
|
942655-44-9
|
Pemigatinib
|
培米加替尼
|
1513857-77-6
|
KHS101 hydrochloride
|
盐酸KHS101
|
1784282-12-7
|
Nintedanib esylate
|
尼达尼布乙磺酸盐
|
656247-18-6
|
Tyrosine kinase-IN-1
|
TYROSINE KINASE-IN-1
|
705946-27-6
|
Fisogatinib
|
BLU554
|
1707289-21-1
|
FGFR4-IN-1
|
CS-2343
|
1708971-72-5
|
PD-166866
|
PD-166866
|
192705-79-6
|
E7090
|
E-7090
|
1622204-21-0
|
E7090 succinate
|
|
1879965-80-6
|
(Z)-Orantinib
|
SU 6668
|
210644-62-5
|
NSC12
|
CS-2161
|
102586-30-1
|